Biogen BIIB Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 301.8%-1.0pp | 301.9%-0.3pp | 302.4%+2.0pp | 302.7%+2.8pp | 302.8%+1.5pp | |
| Net margin | 59.2%-1.6pp | 59.9%+2.2pp | 63.2%+10.6pp | 64.1%+13.6pp | 60.7%-4.5pp | |
| Returns | ||||||
| Return on equity | 34.1%-3.6pp | 35.3%-1.2pp | 38%+3.6pp | 39.2%+4.5pp | 37.7%-9.6pp | |
| Return on invested capital | 31.6%-0.9pp | 32%+0.6pp | 33.5%+3.7pp | 33.8%+3.9pp | 32.6%-7.0pp | |
| Efficiency | ||||||
| Asset turnover | 1.4×0.0× | 1.4×0.0× | 1.4×0.0× | 1.4×-0.1× | 1.4×-0.1× | |
| Liquidity | ||||||
| Current ratio | 11×+4.6× | 9.3×+2.3× | 8×+0.4× | 6.6×-1.5× | 6.3×-2.7× | |
| Leverage | ||||||
| Debt-to-equity | 1.5×0.0× | 1.4×-0.2× | 1.4×-0.2× | 1.4×-0.5× | 1.4×-0.5× | |
| Net debt / EBITDA | 4.9×-0.9× | 4.6×-3.2× | 4.8×-4.7× | 5×-5.5× | 5.9×-3.4× | |
| Per Share | ||||||
| Book value per share | $493.78+9.4% | $483.91+10.1% | $474.37+11.1% | $462.56+11.5% | $451.26+11.3% | |
| Valuation | ||||||
| Market capitalization | $91.77B-12.0% | $84.89B-26.6% | $81.36B-37.8% | $89.06B-36.3% | $104.3B-29.2% | |
| Price / earnings | 63×-10.8× | 57.6×-29.5× | 52.1×-53.7× | 56.8×-57.0× | 73.8×-26.3× | |
| Price / sales | 9.2×-1.6× | 8.5×-3.4× | 8.2×-5.2× | 9.1×-5.1× | 10.8×-4.1× | |
| Price / book | 5×-1.3× | 4.8×-2.5× | 4.7×-3.8× | 5.3×-4.0× | 6.4×-3.7× | |
| EV / EBITDA | 38.8×-9.3× | 36.1×-21.7× | 34.3×-36.2× | 37.8×-39.9× | 48.1×-23.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biogen's profit margins?
- Biogen (BIIB) runs a 75.5% gross margin and a 22.9% operating margin, with a 14.3% net margin.
- Where do Biogen's ratios come from?
- Every ratio is computed from Biogen's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
